Cargando…
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
The rate of SARS-CoV-2 infections in children remains unclear due to many asymptomatic cases. We present a study of cross-sectional seroprevalence surveys of anti-SARS-CoV-2 IgG in 10,358 children recruited in paediatric hospitals across Germany from June 2020 to May 2021. Seropositivity increased f...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170697/ https://www.ncbi.nlm.nih.gov/pubmed/35668073 http://dx.doi.org/10.1038/s41467-022-30482-6 |
_version_ | 1784721492969259008 |
---|---|
author | Sorg, Anna-Lisa Bergfeld, Leon Jank, Marietta Corman, Victor Semmler, Ilia Goertz, Anna Beyerlein, Andreas Verjans, Eva Wagner, Norbert Von Bernuth, Horst Lander, Fabian Weil, Katharina Hufnagel, Markus Spiekerkoetter, Ute Chao, Cho-Ming Naehrlich, Lutz Muntau, Ania Carolina Schulze-Sturm, Ulf Hansen, Gesine Wetzke, Martin Jung, Anna-Maria Niehues, Tim Fricke-Otto, Susanne Von Both, Ulrich Huebner, Johannes Behrends, Uta Liese, Johannes G. Schwerk, Christian Drosten, Christian Von Kries, Ruediger Schroten, Horst |
author_facet | Sorg, Anna-Lisa Bergfeld, Leon Jank, Marietta Corman, Victor Semmler, Ilia Goertz, Anna Beyerlein, Andreas Verjans, Eva Wagner, Norbert Von Bernuth, Horst Lander, Fabian Weil, Katharina Hufnagel, Markus Spiekerkoetter, Ute Chao, Cho-Ming Naehrlich, Lutz Muntau, Ania Carolina Schulze-Sturm, Ulf Hansen, Gesine Wetzke, Martin Jung, Anna-Maria Niehues, Tim Fricke-Otto, Susanne Von Both, Ulrich Huebner, Johannes Behrends, Uta Liese, Johannes G. Schwerk, Christian Drosten, Christian Von Kries, Ruediger Schroten, Horst |
author_sort | Sorg, Anna-Lisa |
collection | PubMed |
description | The rate of SARS-CoV-2 infections in children remains unclear due to many asymptomatic cases. We present a study of cross-sectional seroprevalence surveys of anti-SARS-CoV-2 IgG in 10,358 children recruited in paediatric hospitals across Germany from June 2020 to May 2021. Seropositivity increased from 2.0% (95% CI 1.6, 2.5) to 10.8% (95% CI 8.7, 12.9) in March 2021 with little change up to May 2021. Rates increased by migrant background (2.8%, 4.4% and 7.8% for no, one and two parents born outside Germany). Children under three were initially 3.6 (95% CI 2.3, 5.7) times more likely to be seropositive with levels equalising later. The ratio of seropositive cases per recalled infection decreased from 8.6 to 2.8. Since seropositivity exceeds the rate of recalled infections considerably, serologic testing may provide a more valid estimate of infections, which is required to assess both the spread and the risk for severe outcomes of SARS-CoV-2 infections. |
format | Online Article Text |
id | pubmed-9170697 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91706972022-06-08 Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 Sorg, Anna-Lisa Bergfeld, Leon Jank, Marietta Corman, Victor Semmler, Ilia Goertz, Anna Beyerlein, Andreas Verjans, Eva Wagner, Norbert Von Bernuth, Horst Lander, Fabian Weil, Katharina Hufnagel, Markus Spiekerkoetter, Ute Chao, Cho-Ming Naehrlich, Lutz Muntau, Ania Carolina Schulze-Sturm, Ulf Hansen, Gesine Wetzke, Martin Jung, Anna-Maria Niehues, Tim Fricke-Otto, Susanne Von Both, Ulrich Huebner, Johannes Behrends, Uta Liese, Johannes G. Schwerk, Christian Drosten, Christian Von Kries, Ruediger Schroten, Horst Nat Commun Article The rate of SARS-CoV-2 infections in children remains unclear due to many asymptomatic cases. We present a study of cross-sectional seroprevalence surveys of anti-SARS-CoV-2 IgG in 10,358 children recruited in paediatric hospitals across Germany from June 2020 to May 2021. Seropositivity increased from 2.0% (95% CI 1.6, 2.5) to 10.8% (95% CI 8.7, 12.9) in March 2021 with little change up to May 2021. Rates increased by migrant background (2.8%, 4.4% and 7.8% for no, one and two parents born outside Germany). Children under three were initially 3.6 (95% CI 2.3, 5.7) times more likely to be seropositive with levels equalising later. The ratio of seropositive cases per recalled infection decreased from 8.6 to 2.8. Since seropositivity exceeds the rate of recalled infections considerably, serologic testing may provide a more valid estimate of infections, which is required to assess both the spread and the risk for severe outcomes of SARS-CoV-2 infections. Nature Publishing Group UK 2022-06-06 /pmc/articles/PMC9170697/ /pubmed/35668073 http://dx.doi.org/10.1038/s41467-022-30482-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sorg, Anna-Lisa Bergfeld, Leon Jank, Marietta Corman, Victor Semmler, Ilia Goertz, Anna Beyerlein, Andreas Verjans, Eva Wagner, Norbert Von Bernuth, Horst Lander, Fabian Weil, Katharina Hufnagel, Markus Spiekerkoetter, Ute Chao, Cho-Ming Naehrlich, Lutz Muntau, Ania Carolina Schulze-Sturm, Ulf Hansen, Gesine Wetzke, Martin Jung, Anna-Maria Niehues, Tim Fricke-Otto, Susanne Von Both, Ulrich Huebner, Johannes Behrends, Uta Liese, Johannes G. Schwerk, Christian Drosten, Christian Von Kries, Ruediger Schroten, Horst Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 |
title | Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 |
title_full | Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 |
title_fullStr | Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 |
title_full_unstemmed | Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 |
title_short | Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021 |
title_sort | cross-sectional seroprevalence surveys of sars-cov-2 antibodies in children in germany, june 2020 to may 2021 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170697/ https://www.ncbi.nlm.nih.gov/pubmed/35668073 http://dx.doi.org/10.1038/s41467-022-30482-6 |
work_keys_str_mv | AT sorgannalisa crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT bergfeldleon crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT jankmarietta crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT cormanvictor crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT semmlerilia crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT goertzanna crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT beyerleinandreas crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT verjanseva crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT wagnernorbert crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT vonbernuthhorst crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT landerfabian crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT weilkatharina crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT hufnagelmarkus crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT spiekerkoetterute crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT chaochoming crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT naehrlichlutz crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT muntauaniacarolina crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT schulzesturmulf crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT hansengesine crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT wetzkemartin crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT jungannamaria crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT niehuestim crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT frickeottosusanne crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT vonbothulrich crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT huebnerjohannes crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT behrendsuta crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT liesejohannesg crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT schwerkchristian crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT drostenchristian crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT vonkriesruediger crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 AT schrotenhorst crosssectionalseroprevalencesurveysofsarscov2antibodiesinchildreningermanyjune2020tomay2021 |